It has been shown that the suppression of miR-196a could attenuate resistance to cisplatin in lung cancer cell lines and relates to drug efflux-related proteins such as multidrug resistance1 (MDR1), multidrug resistance associated protein 1 (MRP1), endonuclease non-catalytic subunit (ERCC1), survivin, or Bcl-2 [88]. Here, ABCC1 is linked to lung cancer.